Predictive risk factors for coronary artery abnormalities in Kawasaki disease

By Kim TaeYeun   Choi WookSun   Woo Chan-Wook   Choi ByungMin   Lee JungHwa   Lee KwangChul   Son ChangSung   Lee JooWon  

European Journal of Pediatrics, Vol. 166, Iss. 5, 2007-05 ,pp. : 421-425

Springer Publishing Company

Access to resources Recommend Favorite

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AT INITIATION OF KAWASAKI DISEASE AND THEIR DIFFERENTIAL DIAGNOSIS

By Chen Yinghu   Shang Shiqiang   Zhang Chenmei   Liu Tao   Yang Zihao   Tang Yongmin  

Pediatric Hematology and Oncology, Vol. 27, Iss. 3, 2010-04 ,pp. : 244-249

Informa Healthcare

Access to resources Recommend Favorite

Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?

By Davies Shelby   Gold-von Simson Gabrielle  

Pediatric Cardiology, Vol. 34, Iss. 7, 2013-10 ,pp. : 1756-1756

Springer Publishing Company

Access to resources Recommend Favorite

Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

By Okada Keiko  

European Journal of Pediatrics, Vol. 168, Iss. 2, 2009-02 ,pp. : 181-185

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the Efficacy of Treatment of Kawasaki Disease before Day 5 of Illness

By Fong N. C.   Hui Y. W.   Li C. K.   Chiu M. C.  

Pediatric Cardiology, Vol. 25, Iss. 1, 2004-02 ,pp. : 31-34

Springer Publishing Company

Access to resources Recommend Favorite